Read + Share
Amedeo Smart
Independent Medical Education
Bayraktar S, Zhou JZ, Bassett R, Gutierrez Barrera AM, et al. Clinical outcome and toxicity from taxanes in breast cancer patients with BRCA1 and BRCA2 pathogenic germline mutations. Breast J 2020 Jun 4. doi: 10.1111/tbj.13922.PMID: 32497289
Email
LinkedIn
Facebook
Twitter
Privacy Policy